CLINICAL_TRIALS
trial_result
· 2019-09-09
Clinical Trial Update: "Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" [Phase 3]
Summary
Phase 3 trial assessing safety and efficacy of JZP-110 for excessive sleepiness in obstructive sleep apnea has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jazz Pharmaceuticals | Conditions: Obstructive Sleep Apnea | Phase 3 | Status: COMPLETED | Results posted: 2019-09-09